DOI: 10.3390/s26154984 ISSN: 1424-8220

Dielectrophoretic Enrichment Coupled with Impedance Spectroscopy for Real-Time Bacterial Detection and Antibiotic Susceptibility Testing Using an Interdigitated Wave Electrode Array

Zeeshan, Naeem Iqbal

Antimicrobial resistance (AMR), largely driven by the inappropriate and excessive use of antibiotics, requires rapid and reliable bacterial detection and antibiotic susceptibility testing (AST), as conventional culture-based methods remain time-intensive. Here, we report a real-time, label-free interdigitated wave electrode array (IWEA) that combines dielectrophoretic (DEP) enrichment with impedance spectroscopy for rapid bacterial detection and AST. The proposed IWEA was designed and optimized via COMSOL Multiphysics to enhance DEP-relevant electric-field strength, thereby improving DEP-assisted bacterial enrichment compared to conventional planar interdigitated electrodes. The platform enabled sensitive detection of both Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli) in 0.1× PBS across 10–105 CFU/mL within 30 min using DEP-assisted preconcentration (100 kHz, 10 Vpp), outperforming passive (non-DEP) operation (102–105 CFU/mL). For AST, bacterial responses to vancomycin, gentamicin, and ampicillin were monitored through impedance variations following DEP-based enrichment. Susceptible bacteria produced concentration-dependent reductions in ΔZ/Z0, whereas resistant bacteria showed similar responses to untreated controls. Quantitative assessment yielded CC50 values of 2.86 ± 0.22 µg/mL and 3.06 ± 0.20 µg/mL for vancomycin and gentamicin against S. aureus, and 4.59 ± 0.30 µg/mL for gentamicin against E. coli. Resistance profiles of S. aureus to ampicillin and E. coli to vancomycin and ampicillin were clearly distinguished. SEM imaging and disk diffusion assays independently validated the impedance-derived susceptibility results. Collectively, this IWEA platform offers a rapid, label-free, and quantitative approach for bacterial detection and AST, with strong potential for antimicrobial screening and point-of-care diagnostics.

More from our Archive